We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » MiMedx Gets Untitled Letter For Unapproved Biologics
MiMedx Gets Untitled Letter For Unapproved Biologics
September 13, 2013
CBER handed MiMedx an untitled letter over unregulated biologics, saying its regenerative, human cellular and tissue-based products lack approved BLA or IND applications.